医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集

USP in the

Dr. Reddy’s Laboratories Announces the Launch of Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP in the U.S. Market

ヘルスケア製薬　 TimeLine: Market Reddy's Laboratories Announces the Launch of Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules USP in the

2021年08月31日

Dr. Reddy’s Laboratories Announces the Launch of Albendazole Tablets, USP in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Albendazole Tablets, USP in the U.S. Market

ヘルスケア製薬　 TimeLine: Market Reddy's Laboratories Announces the Launch of Albendazole Tablets USP in the

2021年04月29日

Dr. Reddy’s Laboratories announces the launch of Fluphenazine Hydrochloride Tablets, USP in the U.S. Market

Dr. Reddy’s Laboratories announces the launch of Fluphenazine Hydrochloride Tablets, USP in the U.S. Market

バイオテクノロジーヘルスケア製薬　 TimeLine: Fluphenazine Hydrochloride Tablets Market Reddy's Laboratories Announces the Launch USP in the

2021年02月18日

Dr. Reddy’s Laboratories Announces the Launch of Capecitabine Tablets, USP in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Capecitabine Tablets, USP in the U.S. Market

ヘルスケア製薬　 TimeLine: Market Reddy's Laboratories Announces the Launch of Capecitabine Tablets USP in the

2021年02月17日

Dr. Reddy’s Laboratories announces the First-to-Market launch of the generic version of Ciprodex® (ciprofloxacin 0.3% and dexamethasone 0.1%) Otic Suspension, USP in the U.S. Market

Dr. Reddy’s Laboratories announces the First-to-Market launch of the generic version of Ciprodex® (ciprofloxacin 0.3% and dexamethasone 0.1%) Otic Suspension, USP in the U.S. Market

バイオテクノロジーヘルスケア製薬　 TimeLine: generic version of Ciprodex Market Otic Suspension Reddy's Laboratories announces the First-to-Market launch USP in the

2020年08月11日